89
Views
22
CrossRef citations to date
0
Altmetric
Poverty and Blindness

Trachoma and poverty: unnecessary blindness further disadvantages the poorest people in the poorest countries

, MBBS, , MBBS & , AC MD
Pages 422-428 | Received 07 Jun 2007, Accepted 16 Aug 2007, Published online: 15 Apr 2021

REFERENCES

  • Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844–851.
  • World Health Organization. Report of the 2nd Global Scientific Meeting on Trachoma. WHO/PBD/GET 03.1 2003:10.
  • Mecaskey JW, Knirsch CA, Kumaresan JA, Cook JA. The possibility of eliminating blinding trachoma. Lancet Infect Dis 2003; 3: 728–734.
  • Polack S, Brooker S, Kuper H, Mariotti S, Mabey D, Foster A. Mapping the global distribution of trachoma. Bull World Health Organ 2005; 83: 913–919.
  • Schémann JF, Sacko D, Malvy D, Momo G, Traore L, Bore O, Coulibaly S, Banou A. Risk factors for trachoma in Mali. Int J Epidemiol 2002; 31: 194–201.
  • Taylor HR, West SK, Mmbaga BB, Katala SJ, Turner V, Lynch M, Muñoz B, Rapoza PA. Hygiene factors and increased risk of trachoma in central Tanzania. Arch Ophthalmol 1989; 107: 1821–1825.
  • Hsieh YH, Bobo LD, Quinn TC, West SK. Risk factors for trachoma: 6‐year follow‐up of children aged 1 and 2 years. Am J Epidemiol 2000; 152: 204–211.
  • West SK, Munoz B, Mkocha H, Hsieh YH, Lynch MC. Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol 2001; 8: 137–144.
  • Knirsch C, Mecaskey J, Chami‐khazraji Y, Kilima P, West S, Cook J. Trachoma elimination and a public private partnership: the International Trachoma Initiative (ITI). Chlamydial Infections: Proceedings of the 10th international symposium on human chlamydial infections 2002, San Francisco: 485–494.
  • Baltussen RMPM, Sylla M, Frick KD, Mariotti SP. Cost‐effectiveness of trachoma control in seven world regions. Ophthalmic Epidemiol 2005; 12: 91–101.
  • World Health Organization. Primary Health Care Level Management of Trachoma. Geneva 1993;WHO/PBL/93.33.
  • Myatt M, Limburg H, Minassian D, Katyola D. Field trial of lot quality assurance sampling survey method for rapid assessment of prevalence of active trachoma. Bull World Health Organ 2003; 81: 877–885.
  • Negrel AD, Taylor HR, West S. Guidelines for the rapid assessment for blinding trachoma. Geneva: World Health Organization and International Trachoma initiative 2001; WHO document WHO/PBD/GET/00.8.
  • Wright HR, Vu H, Taylor HR. How to assess the prevalence of trachoma. Br J Ophthalmol 2005; 89: 526–527.
  • Kuper H, Solomon AW, Buchan J, Zondervan M, Foster A, Mabey D. A critical review of the SAFE strategy for the prevention of blinding trachoma. Lancet Infect Dis 2003; 3: 372–381.
  • Thylefors B, Negrel AD, Pararajasegaram R, Dadzie KY. Global data on blindness. Bull World Health Organ 1995; 73: 115–121.
  • Evans TG, Ranson MK, Kyaw TA, Ko CK. Cost effectiveness and cost utility of preventing trachomatous visual impairment: lessons from 30 years of trachoma control in Burma. Br J Ophthalmol 1996; 80: 880–889.
  • Frick KDP, Foster AF, Bah MM, Faal HF. Analysis of costs and benefits of the Gambian Eye Care Program. Arch Ophthalmol 2005; 123: 239–243.
  • Jha H, Chaudary JS, Bhatta R, Miao Y, Osaki‐holm S, Gaynor B, Zegans M, Bird M, Yi E, Holbrook K, Whitcher JP, Lietman T. Disappearance of trachoma from Western Nepal. Clin Infect Dis 2002; 35: 765–768.
  • Courtright P, Hoechsmann A, Metcalfe N, Chirambo M, Noertjojo K, Barrows J, Katz J, Chikwawa Survey Team. Changes in blindness prevalence over 16 years in Malawi: reduced prevalence but increased numbers of blind. Br J Ophthalmol 2003; 87: 1079–1082.
  • Frick KD, Melia BM, Buhrmann RR, West SK. Trichiasis and disability in a trachoma‐endemic area of Tanzania. Arch Ophthalmol 2001; 119: 1839–1844.
  • Dhaliwal P, Nagpal G, Bhatia MS. Health‐related quality of life in patients with trachomatous trichiasis or entropion. Ophthalmic Epidemiol 2006; 13: 59–66.
  • Bowman RJ, Faal H, Myatt M, Adegbola R, Foster A, Johnson GJ, Bailey RL. Longitudinal study of trachomatous trichiasis in the Gambia. Br J Ophthalmol 2002; 86: 339–343.
  • West S, Lynch M, Munoz B, Katala S, Tobin S, Mmbaga BB. Predicting surgical compliance in a cohort of women with trichiasis. Int Ophthalmol 1994; 18: 105–109.
  • Oliva MS, Munoz B, Lynch M, Mkocha H, West SK. Evaluation of barriers to surgical compliance in the treatment of trichiasis. Int Ophthalmol 1998; 21: 235–241.
  • Khandekar R, Mohammed AJ, Courtright P. Recurrence of trichiasis: A long term follow‐up study in the Sultanate of Oman. Ophthalmic Epidemiol 2001; 8: 155–161.
  • West SK, West ES, Alemayehu W, Melese M, Munoz B, Imeru A, Worku A, Gaydos C, Meinert CL, Quinn T. Single‐dose azithromycin prevents trichiasis recurrence following surgery—Randomized trial in Ethiopia. Arch Ophthalmol 2006; 124: 309–314.
  • Reacher M, Munoz B, Alghassany A, Daar AS, Elbualy M, Taylor HR. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol 1992; 110: 667–674.
  • Courtright P. Acceptance of surgery for trichiasis among rural Malawian women. East African Med J 1994; 71: 803–804.
  • Rabiu MA, Abiose A. Magnitude of trachoma and barriers to uptake of lid surgery in a rural community of northern Nigeria. Ophthalmic Epidemiol 2001; 8: 181–190.
  • Bowman RJ, Faal H, Jatta B, Myatt M, Foster A, Johnson GJ, Bailey RL. Longitudinal study of trachomatous trichiasis in The Gambia: barriers to acceptance of surgery. Invest Ophthalmol Vis Sci 2002; 43: 936–940.
  • Nagpal G, Dhaliwal U, Bhatia MS. Barriers to acceptance of intervention among patients with trachomatous trichiasis or entropion presenting to a teaching hospital. Ophthalmic Epidemiol 2006; 13: 53–58.
  • Fry AM, Jha HC, Lietman TM, Chaudhary JS, Bhatta RC, Elliott J, Hyde T, Schuchat A, Gaynor B, Dowell SF. Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal. Clin Infect Dis 2002; 35: 395–402.
  • Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: How frequently should we administer mass chemotherapy. Nature Med 1999; 5: 572–576.
  • Solomon AW, Holland MJ, Burton MJ, West SK, Alexander ND, Aguirre A, Massae PA, Mkocha H, Muñoz B, Johnson GJ, Peeling RW, Bailey RL, Foster A, Mabey DC. Strategies for control of trachoma: observational study with quantitative PCR. [see comment] Lancet 2003; 362 (9379): 198–204.
  • West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon AW, Foster A, Bailey RL, Mabey DC. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 2005; 366: 1296–1300.
  • Chidambaram JD, Alemayehu W, Melese M, Lakew T, Yi E, House J, Cevallos V, Zhou Z, Maxey K, Lee DC, Shapiro BL, Srinivasan M, Porco T, Whitcher JP, Gaynor BD, Lietman TM. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma. JAMA 2006; 295: 1142–1146.
  • Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, Sillah A, Faal H, West SK, Foster A, Johnson GJ, Mabey DC, Bailey RL. Re‐emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma‐endemic Gambian community: a longitudinal study. Lancet 2005; 365: 1321–1328.
  • Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad‐sancho A, Molina S, Safari S, Shao JF, Courtright P, Peeling RW, West SK, Bailey RL, Foster A, Mabey DC. Mass treatment with a single‐dose azithromycin for trachoma. N Engl J Med 2004; 351: 1962–1971.
  • Schachter J, West SK, Mabey D, Dawson CR, Bobo L, Bailey R, Vitale S, Quinn TC, Sheta A, Sallam S, Mkocha H, Mabey D, Faal H. Azithromycin in control of trachoma. Lancet 1999; 354: 630–635.
  • Wright HR, Keeffe JE, Taylor HR. Elimination of trachoma: are we in danger of being blinded by the randomised controlled trial? Br J Ophthalmol 2006; 90: 1339–1340.
  • West S, Muñoz B, Lynch M, Kayongoya A, Chilangwa Z, Mmbaga BB, Taylor HR. Impact of face‐washing on trachoma in Kongwa, Tanzania. Lancet 1995; 345 (8943): 155–158.
  • Ngondi J, Onsarigo A, Matthews F, Reacher M, Brayne C, Baba S, Solomon AW, Zingeser J, Emerson PM. Effect of 3 years of SAFE (surgery, antibiotics, facial cleanliness, and environmental change) strategy for trachoma control in southern Sudan: a cross‐sectional study. Lancet 2006; 368 (9535): 589–595.
  • Khandekar R, Thanah TTK, Thi PD. Impact of face washing and environmental improvements on reduction of active trachoma in Vietnam—a public health intervention study. Ophthalmic Epidemiol 2006; 13: 43–52.
  • Reinhard J, Weber A, Nizetic B, Kupka K, Maxwelll F. Studies in epidemiology and control of seasonal conjunctivitis and trachoma in Southern Morocco. Bull World Health Organ 1968; 39: 497.
  • Brechner RJ, West S, Lynch M. Trachoma and flies—individual vs environmental risk‐factors. Arch Ophthalmol 1992; 110: 687–689.
  • Da cruz L, Dadour IR, Mcallister IL, Jackson A, Isaacs T. Seasonal variation in trachoma and bush flies in north‐western Australian Aboriginal communities. Clin Experiment Immunol 2002; 30: 80–83.
  • West SK, Rapoza P, Munoz B, Katala S, Taylor HR. Epidemiology of ocular chlamydial infection in a trachoma‐hyperendemic area. J Infect Dis 1991; 163: 752–756.
  • Burton MJ, Holland MJ, Faal N, Aryee EA, Alexander ND, Bah M, Faal H, West SK, Foster A, Johnson GJ, Mabey DC, Bailey RL. Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages. Invest Ophthalmol Vis Sci 2003; 44: 4215–4222.
  • Courtright P, Sheppard J, Lane S, Sadek A, Schachter J, Dawson CR. Latrine ownership as a protective factor in inflammatory trachoma in Egypt. Br J Ophthalmol 1991; 75: 322–325.
  • Zerihun N. Trachoma in Jimma, South Western Ethiopia. Trop Med Int Health 1997; 2: 1115–1121.
  • Tielsch JM, West KP Jr, Katz J, Keyvan‐larijani E, Tizazu T, Schwab L, Johnson GJ, Chirambo MC, Taylor HR. The epidemiology of trachoma in Southern Malawi. Am J Trop Med Hyg 1988; 38: 393–399.
  • Emerson PM, Lindsay SW, Alexander N, Bah M, Dibba SM, Faal HB, Lowe KO, Mcadam KP, Ratcliffe AA, Walraven GE, Bailey RL. Role of flies and provision of latrines in trachoma control: cluster‐randomised controlled trial. Lancet 2004; 363: 1093–1098.
  • West S, Lynch M, Turner V, Munoz B, Rapoza P, Mmbaga BB, Taylor HR. Water availability and trachoma. Bull World Health Organ 1989; 67: 71–75.
  • Katz J, West KP Jr, Khatry SK, Leclerq SC, Pradhan EK, Thapa MD, Ram shrestha S, Taylor HR. Prevalence and risk factors for trachoma in Sarlahi district, Nepal. Br J Ophthalmol 1996; 80: 1037–1041.
  • Kupka K, Nizetic B, Reinhard J. Sampling studies on epidemiology and control of trachoma in Southern Morocco. Bull World Health Organ 1968; 39: 547.
  • West SK, Munoz B, Turner VM, Mmbaga BB, Taylor HR. The epidemiology of trachoma in central Tanzania. Int J Epidemiol 1991; 20: 1088–1092.
  • Luna EJ, Medina NH, Oliveira MB, De barros OM, Vranjac A, Melles HH, West S, Taylor HR. Epidemiology of trachoma in Bebedouro State of Sao‐Paulo, Brazil—prevalence and risk‐factors. Int J Epidemiol 1992; 21: 169–177.
  • West S, Nguyen MP, Mkocha H, Holdsworth G, Ngirwamungu E, Kilima P, Munoz B. Gender equity and trichiasis surgery in the Vietnam and Tanzania national trachoma control programs. Br J Ophthalmol 2004; 88: 1368–1371.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.